Skip to main content
Log in

Challenges in pancreas transplantation

  • Review Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Whole-organ pancreas transplantation, either alone or combined with a kidney transplant, is the only definitive treatment for many patients with type 1 diabetes that restores normal glucose homoeostasis and insulin independence. Pancreas transplantation delays, or potentially prevents, secondary diabetes complications and is associated with improvement in patient survival when compared with either patients remaining on the waiting list or those receiving kidney transplant alone. Pancreas transplantation is safe and effective, with 1-year patient survival >97 % and graft survival rates of 85 % at 1 year and 76 % at 5 years in recent UK data. This review focuses on some current areas of interest in pancreas transplantation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nathan DM (2015) Diabetes: advances in diagnosis and treatment. JAMA 314:1052

    Article  CAS  PubMed  Google Scholar 

  2. Patterson CC, Dahlquist GC et al (2009) Incidence trends for childhood type 1 diabetes in Europe during 1983–2993 and predicted new cases 2005–2020: a multicentre prospective registration study. Lancet 373:2027

    Article  PubMed  Google Scholar 

  3. Imperatore G, Boyle JP, SEARCH for Diabetes in Youth study group et al (2012) Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050. Diabetes Care 35:2515

    Article  PubMed  PubMed Central  Google Scholar 

  4. American Diabetes Association (2013) Diabetes statistics. http://diabetes.org/diabetes-basics/diabetes-statistics/

  5. Gregg E, Li Y et al (2014) Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med 370:1514

    Article  CAS  PubMed  Google Scholar 

  6. Preis SR, Hwang S-J et al (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950–2005. Circulation 119:1728–1735

    Article  PubMed  PubMed Central  Google Scholar 

  7. Livingstone SJ, Levin D et al (2015) Estimated life expectancy in a Scottish Cohort with type 1 diabetes, 2008–2010. JAMA 313:37

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gruessner RWG, Gruessner AC (2013) The current state of pancreas transplantation. Nat Rev Endocrinol 3:555

    Article  CAS  Google Scholar 

  9. Redfield RR, Scalea JR, Odorico JS (2015) Simultaneous pancreas and kidney transplantation: current trends and future directions. Curr Opin Organ Transplant 20:94–102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Vaidya A, Muthusamy AS, Hadjianastassiou VG et al (2007) Simultaneous pancreas kidney transplantation: to anticoagulate or not? Is that a question? Clin Transplant 21:554–557

    Article  PubMed  Google Scholar 

  11. Gruessner AC, Gruessner RWG (2012) Pancreas transplant outcomes for the United States and non-United States cases as reported to the United Network for Organ Sharing and the International Pancreas transplant registry as of December 2011. Clin Transpl, p 23

  12. Kandaswamy R, Skeans MA et al (2015) OPTN/SRTR 2013 annual data report: pancreas. Am J Transplant 15(S2):1–20

    Article  PubMed  Google Scholar 

  13. National Clinical Guideline Centre (UK) (2015) Type 1 diabetes in adults: type 1 diabetes in adults: diagnosis and management. National Institute for Health and Care Excellence (UK), London

    Google Scholar 

  14. Elwen FR, Huskinson A et al (2015) An observational study of patient characteristics and mortality following hypoglycemia in the community. BMJ Open Diabetes Res Care 3:e000094

    Article  PubMed  PubMed Central  Google Scholar 

  15. Khunti K, Davies M et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes Care 38:316

    Article  PubMed  Google Scholar 

  16. Groop PH, Thomas MC, FinnDiane Study Group et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651–1658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rosolowsky ET, Skupien J et al (2011) Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 22:545–553

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Haapio M, Helve J et al (2010) Survival of patients with type 1 diabetes receiving renal replacement therapy 1980–2007. Diabetes Care 33:1718–1723

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rana A, Gruessner A et al (2015) Survival benefit of solid-organ transplant in the United States. JAMA Surg 150:252–259

    Article  PubMed  Google Scholar 

  20. Weiss AS, Smits G, Wiseman AC (2009) Simultaneous pancreas-kidney versus deceased donor kidney transplant: Can a fair comparison be made? Transplantation 87:1402–1410

    Article  PubMed  Google Scholar 

  21. Weiss AS, Smits G, Wiseman AC (2009) Twelve-month pancreas graft function significantly influences survival following simultaneous pancreas-kidney transplantation. Clin J Am Soc Nephrol 4:988–995

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wiseman AC, Huang E, Kamgar M, Bunnapradist S (2013) The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes. Nephrol Dial Transplant 28:1047–1058

    Article  PubMed  Google Scholar 

  23. Sung RS, Zhang M, Schaubel DE, Shu X, Magee JC (2015) A reassessment of the survival advantage of simultaneous kidney-pancreas versus kidney-alone transplantation. Transplantation 99:1900–1906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kahn SE, Cooper ME, Del Prato S (2014) Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383:1068–1083

    Article  CAS  PubMed  Google Scholar 

  25. Covic AM, Schelling JR, Constantiner M, Iyengar SK, Sedor JR (2000) Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients. Kidney Int 58:1742–1750

    Article  CAS  PubMed  Google Scholar 

  26. Sasaki TM, Gray RS et al (1998) Successful long-term kidney-pancreas transplants in diabetic patients with high C-peptide levels. Transplantation 65:1510–1512

    Article  CAS  PubMed  Google Scholar 

  27. Wiseman AC, Gralla J (2012) Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes. Clin J Am Soc Nephrol 7:656–664

    Article  PubMed  Google Scholar 

  28. Stratta RJ, Rogers J et al (2015) Pancreas transplantation in C-peptide positive patients: Does “type” of diabetes really matter? J Am Coll Surg 220:716–727

    Article  PubMed  Google Scholar 

  29. Ciancio G, Burke GW (2014) Type 2 diabetes: Is pancreas transplantation an option? Curr Diabetes Rep 14:542

    Article  CAS  Google Scholar 

  30. Denecke C (2015) The bionic pancreas: novel perspectives on insulin replacement therapies. Transplantation 99:268–269

    Article  PubMed  Google Scholar 

  31. Russell SJ, El-Khatib FH et al (2014) Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med 371:313–325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Fiorina P, Vezzulli P, Bassi R et al (2012) Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care 35:367–374

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Gremizzi C, Vergani A, Paloschi V, Secchi A (2010) Impact of pancreas transplantation on type 1 diabetes-related complications. Curr Opin Organ Transplant 15:119–123

    Article  PubMed  Google Scholar 

  34. Perseghin G, Fiorina P, De Cobelli F et al (2005) Cross-sectional assessment of the effect of kidney and kidney-pancreas transplantation on resting left ventricular energy metabolism in type 1 diabetic-uremic patients: a phosphorous-31 magnetic resonance spectroscopy study. J Am Coll Cardiol 46:1085–1092

    Article  PubMed  Google Scholar 

  35. Lindahl JP, Hartmann A, Aakhus S et al (2016) Long-term cardiovascular outcomes in type 1 diabetic patients after simultaneous pancreas and kidney transplantation compared with living donor kidney transplantation. Diabetologia 59:844–852

    Article  CAS  PubMed  Google Scholar 

  36. Dieterle CD, Arbogast H et al (2007) Metabolic follow-up after long term pancreas graft survival. Eur J Endocrinol 156:603–610

    Article  CAS  PubMed  Google Scholar 

  37. Pfeffer F, Nauck MA et al (2003) Postoperative oral glucose tolerance and stimulated insulin secretion: a predictor of endocrine graft function more than 10 years after pancreas kidney transplantation. Transplantation 76:1427–1431

    Article  CAS  PubMed  Google Scholar 

  38. Troppmann C, Gruessner AC et al (1996) Delayed endocrine pancreas graft function after simultaneous pancreas-kidney transplantation. Incidence, risk factors, and impact on long-term outcome. Transplantation 61:1323–1330

    Article  CAS  PubMed  Google Scholar 

  39. Mittal S, Nagendran M et al (2014) Postoperative impaired glucose tolerance is an early predictor of pancreas graft failure. Diabetologia 57:2076–2080

    Article  CAS  PubMed  Google Scholar 

  40. Mittal S, Franklin RH et al (2015) Early postoperative continuous glucose monitoring in pancreas transplant recipients. Transpl Int 28:604–609

    Article  CAS  PubMed  Google Scholar 

  41. Faradji RN, Froud T et al (2009) Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Cell Transplant 18(10):1247–1259

    Article  PubMed  Google Scholar 

  42. Wang Y, Qi M et al (2013) Use of glucagon-like peptide-1 agonists to improve islet graft performance. Curr Diabetes Rep 13:723–732

    Article  CAS  Google Scholar 

  43. Rickels MR, Naji A (2010) Reactive hypoglycaemia following GLP-1 infusion in pancreas transplant recipients. Diabetes Obes Metab 12:731

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Lerche S, Soendergaard L (2009) No increased risk of hypoglycaemic episodes during 48h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrinol 71:500–506

    Article  CAS  Google Scholar 

  45. Cariou B, Bernard C, Cantarovich D (2015) Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: a case series. Diabetes Metab 41:252–257

    Article  CAS  PubMed  Google Scholar 

  46. Dean PG, Kudva YC, Larson TS, Kremers WK, Stegall MD (2008) Post-transplant diabetes mellitus after pancreas transplantation. Am J Transplant 8(1):175–182

    CAS  PubMed  Google Scholar 

  47. Vendrame F, Pileggi A et al (2010) Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells. Diabetes 59:947–957

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Ishida-Oku M, Iwase M et al (2010) A case of recurrent type 1 diabetes mellitus with insulitis of transplanted pancreas in simultaneous pancreas-kidney transplantation from cardiac death donor. Diabetologia 53:341–345

    Article  CAS  PubMed  Google Scholar 

  49. Braghi S, Bonifacio E, Secchi A, Di Carlo V, Pozza G, Bosi E (2000) Modulation of humoral islet autoimmunity by pancreas allotransplantation influences allograft outcome in patients with type 1 diabetes. Diabetes 49:218–224

    Article  CAS  PubMed  Google Scholar 

  50. Vendrame F, Hopfner YY et al (2016) Risk factors for type 1 diabetes recurrence in immunosuppressed recipients of simultaneous pancreas-kidney transplants. Am J Transplant 16:235–245

    Article  CAS  PubMed  Google Scholar 

  51. Mittal S, Page SL, Friend PJ, Sharples EJ, Fuggle SV (2014) De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure. Am J Transplant 14:1664–1671

    Article  CAS  PubMed  Google Scholar 

  52. Drachenberg CB, Papadimitriou JC (2007) Spectrum of histopathological changes in pancreas allograft biopsies and relationship to graft loss. Transplant Proc 39:2326–2328

    Article  CAS  PubMed  Google Scholar 

  53. Papadimitriou JC, Drachenberg CB (2012) Distinctive morphological features of antibody-mediated and T-cell-mediated acute rejection in pancreas allograft biopsies. Curr Opin Organ Transplant 17:93–99

    Article  CAS  PubMed  Google Scholar 

  54. León Fradejas M, Kandil D et al (2015) Islet amyloid in whole pancreas transplants for type 1 diabetes mellitus (DM): possible role of type 2 DM for graft failure. Am J Transplant 15:2495–2500

    Article  CAS  PubMed  Google Scholar 

  55. OPTN/UNOS pancreas transplant committee report to committee June 2015. http://optn.transplant.hrsa.gov/converge/CommitteeReports/board_main_PancreasTransplantationCommittee_6_3_2015_18_15.pdf

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. J. Sharples.

Ethics declarations

Conflict of interest

None.

Human and animal rights

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Informed consent

For this type of study, informed consent is not required.

Additional information

Managed by Antonio Secchi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharples, E.J., Mittal, S.M. & Friend, P.J. Challenges in pancreas transplantation. Acta Diabetol 53, 871–878 (2016). https://doi.org/10.1007/s00592-016-0865-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-016-0865-x

Keywords

Navigation